Cite
MLA Citation
U. Novak et al.. “SAKK 36/13–IBRUTINIB AND BORTEZOMIB FOLLOWED BY IBRUTINIB MAINTENANCE IN PATIENTS WITH RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA: PHASE I REPORT OF A PHASE I/II TRIAL.” Hematological oncology, vol. 35, n.d., p. 207. http://access.bl.uk/ark:/81055/vdc_100047412233.0x000036